This study compared results from Gd-EOB-DTPA on two different phases of 3T MRI with those from Tc-99m-GSA hepatic scintigraphy and hepatic function tests. Twenty-four patients with liver tumor were included in this study. All patients underwent Gd-EOB-DTPA-enhanced-MRI and Tc-99m-GSA hepatic scintigraphy. Clearance index HH15 and receptor index LHL15 were calculated for the Tc-99m-GSA, while signal intensities SI of liver at pre-injection and at 4 / 20 min post-injection, and of spleen at 4 min / 20 min were measured SI pre , SI 4min , SI 20min , SI sp4min , SI sp20min , respectively for the Gd-EOB-DTPA-MRI. Liver activity at 15 min by Tc-99m-GSA scintigraphy or biochemical liver function values were compared with liver spleen contrast at 4 min LSC 4min SI 4min / SI sp4min or 20 min postinjection LSC 20min SI 4min / SI SP20min , and the increase in ratio at 4 min IR 4min SI 4min / SI sp4min or 20 min IR 20min SI 20min / SI pre . Total bilirubin levels T-bil , serum albumin levels Alb , prothrombin activity, and the indocyanine green clearance test ICG results were also analyzed. There were statistically significant correlations in all comparisons between Gd-EOB-DTPA and Tc-99m-GSA. The highest coefficient of correlation was obtained in IR 4min LHL15 : r 0.795, P 0.001 ; HH15 : r 0.782, P 0.001 , with IR 20min LHL15 : r 0.690, P 0.01 ; HH15 : r 0.528, P 0.05 , LSC 4min LHL15 : r 0.458, P 0.05 ; HH15 : r 0.626, P 0.05 , and LSC 20min LHL15 : r 0.443, P 0.05, HH15 : r 0.609, P 0.05 also signi cantly correlated. Correlations in hepatic function data were observed between IR 4min and T-bil / Alb, and IR 20min and Alb. In 3T-MRI using Gd-EOB-DTPA, the SI of liver at pre-to post-injection especially at 4 min signi cantly correlated with the corresponding Tc-99m-DTPA scintigraphy results, and with some biochemical liver function data.
Introduction
Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid Gd-EOB-DTPA has been widely used as a magnetic resonance imaging MRI contrast medium for the diagnosis of liver tumors, including hepatoma, and its usefulness for evaluating hepatic function has been demonstrated by a number of studies [1] [2] [3] [4] . Approximately 40 of Gd-EOB-DTPA administered to the body is excreted in bile and thus its use in the evaluation of hepatic function has been considered since the development of this approach. The Child-Pugh classi cation and the uptake of ethoxybenzyl EOB in the liver were thus also used to con rm the reduction in signal enhancing effect in the hepatic parenchyma of patients with severe hepatic dysfunction [1] [2] [3] [4] [5] . Technetium-99m-galactosyl human serum albumin Tc-99m-GSA has also been used in the clinical setting to visually assess hepatocellular function since the rst half of 1990.
This medium is taken up by hepatocytes via asialoglycoprotein receptors on the hepatic membrane and is excreted in bile. There are various analytical methods for the evaluation of hepatic function using Tc-99m-GSA, with the most widely used being the clearance index HH15 and the receptor index LHL15 . These indicators are easy to use and show good correlation with hepatic reserve 6, 7 ; they have also been used recently in postoperative follow-up for hepatectomy, preoperative volumetry assessment of liver remnant functions 8, 9 , and evaluation of hepatic functions after living donor liver transplantation 9, 10 .
Both Gd-EOB-DTPA and Tc-99m-GSA are taken up by hepatocytes and excreted in bile, and it is therefore reasonable to assume that both could be used to evaluate hepatic function. Indeed, previous comparisons of liver spleen contrast LSC 1 as well as bile duct signal 11 and hepatic functions have demonstrated correlations between Gd-EOB-DTPA and hepatic function. Here we tested this assumption by comparing the increase ratio IR of the liver signal / LSC when MRI was performed using Gd-EOB-DTPA with HH15 and LHL15 obtained using Tc-99m-GSA and hepatic function testing. It should be noted that a similar previous study focused on the hepatobiliary phase 1, 2 ; however, the excretion to bile from hepatocytes differs between EOB and GSA. We therefore assessed Gd-EOB-DTPA-enhanced MRI both at the phase less in uenced by the excretion to bile and the hepatobiliary phase.
Subjects and Methods
The subjects included 24 patients 16 males and 8 females who underwent both preoperative Gd-EOB-DTPA-enhanced MRI using the 3- acquisition time, 21 s . The patients were instructed to fast for at least three hours or more before the test. Gd-EOB-DTPA 0.025 mmol / kg body weight was intravenously infused at 2 ml / s, and subsequently ushed out with 20 ml of physiological saline. Images were taken before, and at 4 and 20 min after injection of the contrast material.
The signal intensity SI of the liver was measured in a region of interest ROI of approximately 150 mm 2 in the medial and lateral segments of the left lobe, and in the anterior and posterior segments of the right lobe. The average of these values was determined as the signal intensity of the liver SI L . The spleen SI was measured in two ROIs, at the anterior and posterior segments of the spleen in the same slice as that used above, and the average was determined as SI S . SI L and SI S were measured before injection, and at 4
and 20 min after contrast material injection. Increase ratio IR and liver spleen contrast LSC before imaging relative to those 4 and 20 min after contrast material injection were calculated using the following formulae : 
Tc-GSA scintigraphy
The patients were instructed to fast for three hours or more before testing, and then were intravenously infused with 185 MBq of 99mTc-GSA, which was ushed out with 40 ml of physiological saline. Images were taken using a PRISM 2000XP scintillation camera Philips Picker with a dual-head system and a low-energy high-resolution collimator. A frontal view was taken in the supine position. Serial scans were acquired with the collection matrix of 128 128, 15 s / frame 80 frames 20 min . Image processing Odyssey : Philips Picker , was used to select the ROIs over the heart and liver for each time activity curve, which were used to obtain the counts for the heart and liver at 3 and 15 min after the intravenous infusion. HH15 and LHL15 were calculated using the following formulae :
HH15 heart count at 15 min / heart count at 3 min LHL15 liver count at 15 min / sum of liver and heart counts at 15 min
Statistical Analysis
The correlation coef cients between IR 4min , IR 20min , LSC 4min , LSC 20min , HH15, and LHL15, and the biochemical test data including total bilirubin T-bil , albumin Alb , prothrombin time PT , ICG R15 n 19 , and estimated glomerular ltration rate eGFR were obtained.
Signi cance levels were set at P 0.05.
Results
The correlations among the IR of the liver signal at 4 min IR 4min and 20 min IR 20min after the infusion, the LSC at 4 min LSC 4min and 20 min LSC 20min after the infusion, and HH15 and LHL15 are shown in Fig. 1 ad and Table 1 . Signi cant correlations were found between HH15 / LHL15 and both liver IR and LSC. The highest correlation coef cient was observed between IR 4min and LHL15, while the correlations of LHL15 with LSC 4min and LSC 20min were lower than those measured among the other parameters. The correlation coef cient of HH15 / LHL15 with the liver IR was greater for IR 4min than for IR 20min .
Correlations with hepatic function examination data were observed between IR 4min and T-bil / Alb, and between IR 20min and Alb, but there were no correlations for LSC 4min and LSC 20min Table 2 . From the changes over time in liver SI after the infusion, the intensity 20 min after the infusion increased in 21 subjects 87. 5 and decreased in 3 subjects 12.5 , compared with 4 min after the infusion Fig. 2 . The latter subjects were all classi ed as Class A according to the Child-Pugh classi cation.
In this study, no visualization of contrast media in ow to the bile ducts was observed at 4 min after the infusion, while the bile ducts were visible in all cases at 20 min after the infusion. There were no differences in bile duct SIs between the groups with lowered and increased SI in the hepatic parenchyma 20 min after the infusion. The mean relative SI, excluding signal decreases at 20 min, was 4.70 1.79. In the signal-decreased group, only one patient showed a higher than average SI relative SI 7.62 ; for the other two patients, SI was below the average value relative SI 2.38 and 2.62, respectively .
In three patients, Gd-EOB-DTPA did not reach the bile duct completely, thus these cases were excluded from the signal-decreased group. The primary diseases of these cases was hepatocellular carcinoma in one patient, hepatic metastases in one patient, and cholangiocellular carcinoma in one patient, and the size was 2.8 cm, 1.8 cm, and 1.2 cm in diameter, respectively. The hepatocellular carcinoma and hepatic metastases both developed in the margin of the liver and there were no ndings suggesting intrahepatic biliary stenosis. On the other hand, the patient with cholangiocellular carcinoma had stenosis in the intrahepatic bile duct of the left lobe, and contrast media in ow was visualized in the intrahepatic bile duct of the right lobe and in part of the bile duct, but not in the intrahepatic bile duct of the left lobe. IR 4min of these 3 patients ranged from 1.56 to 1.85, the SI gradually increased up to 20 min after the infusion, and Gd-EOB-MRI revealed no distinct ndings. The Child-Pugh classi cation of these cases was Class A. In addition, the ICG test result was slightly high in the patient with hepatocellular carcinoma and the patient with hepatic metastases 11 and 16 , respectively , while it was normal in the patient with cholangiocellular carcinoma 4 .
When all patients in this study were divided according to the primary disease into the hepatocellular carcinoma group n 14 and non-hepatocellular carcinoma group n 10 , the correlations between IR 4min and LHL15 were signi cantly different at R 0.766 P 0.01 and R 0.690 P 0.05 , respectively. Dividing the non-hepatocellular carcinoma group further into the hepatic metastases group n 5 and cholangiocellular carcinoma group n 5 produced no signi cant differences in the same correlation R 0.800 and R 0.719, respectively .
Discussion
In this study, the IR in the hepatic parenchyma before the EOB infusion, and at 4 and 20 min after the EOB infusion, and the LSC at 4 and 20 min after the infusion were used as evaluation parameters of Gd-EOB-DTPA for correlative comparison with HH15 and LHL15 of Tc-99m-GSA and various hepatic function evaluation data. The IR in the hepatic parenchyma and the LSC correlated positively with HH15 and LH15, with the coef cients of correlation in both cases higher at 4 min after the infusion than at 20 min after the infusion. In addition, hepatic function indicators, T-bil and Alb, correlated strongly with the IR in the hepatic parenchyma, but not with LSC.
Among previous studies that evaluated hepatic function using Gd-EOB-DTPA, Motosugi et al 1 showed a correlation between the LSC and hepatic function, while Takao et al 11 reported that the relative SI ratios of skeletal muscles to the right and left hepatic ducts, common hepatic duct, and common bile duct delayed the rate of SI increase in patients with chronic liver disease, that the rate of SI increase was slower in the chronic liver disease group than in the normal group, and that SI signi cantly correlated with ICG15.
Finally, Nishie et al 2 demonstrated that Gd-EOB-DTPA-enhanced-MRI results of liver-tospleen SI ratio and liver-to-major psoas muscle SI on the hepatobiliary phase were both well correlated with HH15 and LHL15. Thus, Gd-EOB-DTPA-enhanced MRI is expected to be useful for evaluating hepatic function in a similar way to the more widely used Tc-99m-GSA. In general, HH15 can re ect mild hepatic dysfunction and LHL15 can indicate severe hepatic dysfunction. In this study, Tc-99m-GSA indicated a strong correlation with LHL15 for all patients except those with severe hepatic dysfunction according to the Child-Pugh classification. This seemingly incompatible finding might result from the fact that LHL15 re ects the accumulation of signal in the liver and thus has a stronger relationship with the rate of increase in hepatic signal. Furthermore, the Tc-99m-GSA parameters re ect the rate of increase in RI accumulation at 3 and 15 min. Therefore, the IR of the liver signal used in this study might be pharmacokinetically more similar to Tc-99m-GSA than LSC, because both IR and Tc-99m-GSA directly re ect uptake and excretion to hepatocytes.
The uptake of Tc-99m-GSA in the liver may peak at 15 min after the infusion, and RI excretion from the hepatocytes could be ignored in the compartment model if it is only for 30 min. On the other hand, following the Gd-EOB-DTPA infusion, EOB was excreted in bile at an earlier stage than Tc-99m-GSA. Moreover, EOB is reportedly excreted in bile by 5 to 16 min after intravenous Gd-EOB-DTPA infusion in a normal liver 12 , suggesting that EOB might be taken up by the cells 4 min after the infusion and the duration recorded might be the phase where the excretion to bile or blood ow was in uenced less. In addition, in terms of the changes in liver SI over time after Gd-EOB-DTPA infusion, the signal increased 20 min after the infusion in the majority of subjects compared with that recorded 4 minutes after the infusion. However, it also decreased in 3 subjects, suggesting that the uptake of EOB into the liver might be lower according to the evaluation of this phase alone. EOB is secreted at least into the bile canaliculus and sinusoid. As for the cause of the excretion from hepatocytes, the excretory pathway could undergo changes in the presence of vascular lesions and / or biliary tract lesions and / or the rate of excretion to the sinusoid or bile canaliculus could vary among individuals. Both or either of these events could produce differences in the excretion of Gd-EOB-DTPA from the hepatic parenchyma, which is likely to influence the SI. It remains unclear from the data why the SI was decreased at 20 min in some patients ; however, it was assumed that in the 3 patients with signal decreases at 20 min the bile duct SI was increased because of accelerated excretion of Gd-EOB-DTPA from the liver cells, and these intensities varied widely. As far as we know, there are no reports on SIs in hepatic parenchyma or bile ducts, and further study is clearly needed.
This study result indicated that the correlation coef cient between the bilirubin level and The present study also found no correlation between IR 20min and serum bilirubin level, but a signi cant difference was observed with IR 4min , suggesting that the shorter time after infusion better re ected the excretory capacity of hepatic cells. Previous literature indicates that ICG15 showed the strongest correlation with some biochemical liver functional data 7, 9 , but this study could not reproduce these ndings. Likewise, this study showed only a slight correlation with HH15 when Tc-99m-GSA was used. Factors underlying this contradiction might be the low number of subjects tested for ICG15, the small population 19 / 24 patients , and the accuracy of the test. However, no apparent cause could be found in the evaluable data and further studies are required. Unlike bilirubin, ICG enters hepatocytes via receptors according to individual hepatic function before being released into the bile canaliculus. Both these substances are excreted into the bile duct but are not released into the blood, suggesting that the kinetics were similar to those of Tc-99m-GSA.
Three cases in this study showed no complete visualization of contrast media inflow to the bile ducts at 20 min after the infusion. Takao et al 11 reported a peak SI in the bile ducts of normal liver at 30 min after infusion, while patients with hepatic dysfunction showed a peak delay and low SI. However, neither serological hepatic dysfunction nor any causes of stenosis, such as stones or tumors in the bile ducts, was observed in the present cases without complete visualization at 20 min after the infusion. The timing of bile excretion of Gd-EOB-DTPA varies among individuals, and was earlier than the peak time of the contrast effect in the bile ducts. Therefore, it was not clear whether the above-mentioned facts were directly re ected in the impaired bile excretion. The presence of mild cholangitis was suspected, although there were no effects on IR, HH15, or LHL15.
According to primary disease, the patients with hepatocellular carcinoma in this study might have had liver parenchymal injury caused by hepatitis and hepatic cirrhosis. The measurements were scattered, but the coef cient of correlation was slightly higher than that in the non-hepatocellular carcinoma group. Among the non-hepatocellular carcinoma group, the correlation between results of Gd-EOB-DTPA and Tc-99m-GSA was slightly lower in the cholangiocellular carcinoma group than in the hepatic metastases group. These ndings suggested that the presence or absence of bile duct stenosis could affect excretion from the hepatic parenchyma, but the majority 87.5 of cases in this study had contrast media in ow to the bile ducts 20 min after the infusion and this study could not elucidate whether liver parenchymal injury occurred. Finally, Kim et al 13 reported that bile duct stenosis is less likely to in uence the excretion of Gd-EOB-DTPA. A larger study is required to elucidate these points.
A limitation of this study was that it was retrospective and in patients who were sched-uled to undergo hepatectomy, thus there were relatively few participants and none of Grade C in the Child-Pugh classi cation. Nishie et al 2 reported good correlations in contrast ratio between the liver and iliopsoas with Tc-99m-GSA, and between the liver and spleen with LHL15 and HH15. Motosugi et al 1 also reported that there were signi cant correlations of the contrast ratios of liver and spleen with blood data. However, the present ndings showed no significant correlations among LSC, Tc-99m-GSA, and blood data. Neither heterogeneity of the spleen parenchyma nor apparent stenosis in the splenic artery and vein was observed in this study, and so the cause for these differences in study results remains unknown. A larger prospective study should be performed in the future to clarify this issue, and to consider other timings after the infusion.
The costs to patients and the time needed for Tc-99m-GSA and Gd-EOB-MRI are approximately equal in Japan. Gd-EOB-MRI remains the standard test for hepatocellular carcinoma and hepatic metastases, and if the usefulness of Gd-EOB-MRI for assessing hepatic reserve is established, Tc-99m-GSA will no longer be used. However, Tc-99m-GSA was slightly better in the relationship with the liver function data in this study and methods for measuring Gd-EOB-MRI vary according to the literature. Therefore, a standard method of assessing hepatic reserve using Gd-EOB-MRI should be established like those used for Tc-99m-GSA. Currently, Tc-99m-GSA should be the rst choice ; however, in the case of applying Gd-EOB-MRI alone, the method used in this study will be worthwhile in the clinical setting.
Furthermore, the results suggested that Gd-EOB-DTPA-enhanced MRI could be used to assess hepatic reserve by determining the increase in liver signal similar to Tc-99m-GSA.
Conclusion
There were signi cant correlations between the IR of the liver signal and the LSC as shown by Gd-EOB-DTPA-enhanced MRI, and between HH15 and LHL15 as demonstrated by Tc-99m-GSA scintigraphy. The highest coef cient of correlation was obtained with the IR at 4 min, suggesting that IR of the liver signal measured by Gd-EOB-DTPA-enhanced MRI might be a useful parameter for evaluating hepatic function.
